prices
23.03.2017
Cassation Court pronounced legitimacy of FAS refusal to increase threefold prices for “Prostenongel” medicinal drugmore
Earlier Courts of two instances confirmed legitimacy of the efforts of the antimonopoly body and the rightness of applying the established requirements to register prices for vital and essential drugs
more
On 14 March, FAS found that “Apple Rus” Ltd. had coordinated economic activity of Apple iPhone Smartphone resellers that resulted in fixing and marinating prices for them (in breach of Part 5 Article 11 of the Federal Law “On Protection of Competition”)
more
Pharmaceutical companies continue reducing drug prices upon the findings of an international comparative survey carried out by FAS
more
The FAS Russia established that the drug manufacturer submitted false information on the prices of raw materials supplies and set an excessive euro exchange rate in its estimates
more
The FAS Russia considered a petition of “Johnson & Johnson” Ltd. on the need to re-file a proposal to include medicinal drugs in the list of vital and essential drugs for 2018
more